Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 8Pancreatic Neoplasms 7Breast Neoplasms 7Colorectal Neoplasms 6Stomach Neoplasms 5Neoplasms 5Sarcoma 3Precision Cell Immunotherapy 3Ovarian Neoplasms 3Neoplasm Metastasis 3Mesothelioma, Malignant 3Lung Neoplasms 3Leukemia, Myeloid, Acute 3Hodgkin Disease 3Glioblastoma 3Esophageal Neoplasms 3Wilms Tumor 2Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Mesothelioma 2Melanoma 2Lymphoma 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Esophageal Squamous Cell Carcinoma 2Colonic Neoplasms 2Cholangiocarcinoma 2Carcinoma, Ovarian Epithelial 2Virus Diseases 1

Interventions

Whole-Body Irradiation 4fludarabine 3Cyclophosphamide 3AP 1903 reagent 3fludarabine phosphate 2Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Melphalan 2Alemtuzumab 2Thiotepa 1Sirolimus 1Pentostatin 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1In Situ Hybridization, Fluorescence 1Immunoenzyme Techniques 1Flow Cytometry 1Drug Therapy 1Cytogenetic Analysis 1Cyclosporins 1Cyclosporine 1Busulfan 1Antilymphocyte Serum 111-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Anemia, Aplastic × Drug Therapy × Clear all
NCT02145923 2015-06-10

Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis

Burnasyan Federal Medical Biophysical Center

Phase 1/2 Unknown
16 enrolled
Classical hematologyLymphoid

Anemia, Aplastic, Hodgkin Disease, Enterocolitis, Neutropenic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡